STOCK TITAN

bioAffinity Technologies: HRT Financial reports 10.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

bioAffinity Technologies, Inc. (BIAF) common stock was the subject of HRT Financial LP’s beneficial-ownership report. HRT reported 127,132 shares beneficially owned as of September 30, 2026, including 126,146 shares held directly and 986 shares issuable upon exercise of certain warrants. The reported stake was 10.9% of the class, calculated using 1,166,625 shares outstanding as of September 30, 2026, plus the 986 warrant shares, for a denominator of 1,167,611 shares.

Beneficially owned shares 127,132 shares HRT Financial LP’s reported amount as of September 30, 2026
Directly held shares 126,146 shares Included in HRT Financial LP’s reported beneficial ownership
Warrant shares 986 shares Common shares issuable upon exercise of certain warrants held by HRT Financial LP
Percentage of class 10.9% HRT Financial LP’s reported beneficial ownership
Shares outstanding 1,166,625 shares bioAffinity Technologies common stock as of September 30, 2026
beneficially owned regulatory
"Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power regulatory
"Sole Voting Power 127,132.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole Dispositive Power 127,132.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
warrants financial
"shares of Common Stock issuable upon the exercise of certain warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BIAF shares did HRT Financial LP report beneficially owning?

HRT Financial LP reported 127,132 shares beneficially owned as of September 30, 2026. The amount included 126,146 shares held directly and 986 shares issuable upon exercise of certain warrants.

What percentage of BIAF did HRT Financial LP report?

HRT reported 10.9% of the class. Its calculation used 1,166,625 shares of Common Stock outstanding as of September 30, 2026, plus 986 shares issuable upon exercise of certain warrants, for a denominator of 1,167,611 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





09076W406

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is based on 1,166,625 shares of Common Stock outstanding as of September 30, 2026, as reported by bioAffinity Technologies, Inc. in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the Securities and Exchange Commission on November 6, 2026, plus 986 shares of Common Stock issuable upon the exercise of certain warrants held by HRT Financial LP, for a denominator of 1,167,611 shares.


SCHEDULE 13G



HRT FINANCIAL LP
Signature:Adam Nunes
Name/Title:CEO
Date:11/19/2026

Keep reading